When crisis strikes, how do groups of people find their way back to harmony? A fascinating Israeli research study might have found the answer—through the unlikely combination of violins, headphones, and network science.

In a significant step forward for cancer immunotherapy, biotechnology company Pluri has announced a collaboration with Bar-Ilan University to advance MAIT cell therapy for solid tumors. The partnership, supported by the Israel Innovation Authority, brings together cutting-edge cellular technology with innovative genetic engineering to tackle one of medicine's most challenging frontiers: solid tumors.

As the global diabetes epidemic continues to escalate—quadrupling since 1980—the Russell Berrie Galilee Diabetes Social Precision-medicine Health Equity Research Endeavour (SPHERE) at Bar-Ilan University’s Azrieli Faculty of Medicine is tackling various aspects of this pressing international health crisis.

The announcement came at the start of the 2024-25 academic year, marking a significant shift in the university's strategic approach to industry collaboration.